Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

3.81
BATS BZX Real-Time Price
As of 9:38am ET
 -0.21 / -5.22%
Today’s Change
3.90
Today|||52-Week Range
19.68
-47.08%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close4.02
Today’s open3.93
Day’s range3.81 - 3.93
Volume3,363
Average volume (3 months)301,978
Market cap$110.0M
Dividend yield--
Data as of 9:38am ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+59.62%
Earnings growth (this year)+21.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.93

Competitors

 Today’s
change
Today’s
% change
RKDAArcadia Biosciences ...0.000.00%
ONTYOncothyreon Inc-0.07-6.09%
PRTOProteon Therapeutics...0.000.00%
QLTIQLT Inc0.000.00%
Data as of 9:37am ET, 02/08/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$18.3M
Net profit margin--

Profile

Sector
Industrial Services
Industry
Engineering & Construction
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers